SecurityTSBK / Timberland Bancorp, Inc. (887098101)
President and CEOSAND MICHAEL R
IndustrySavings Institutions, Not Federally Chartered
Institutional Owners67
Institutional Shares4,654,084 - 62.95%
Common Shares Outstanding7,392,827 shares (as of 2018-03-31)
Institutional Value$ 200,635,000 USD
Related TBSK / TIMBERLAND BANCORP INC

Institutional Stock Ownership and Shareholders()

Timberland Bancorp, Inc. (NASDAQ:TSBK) has 67 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,654,084 shares. Largest shareholders include Dimensional Fund Advisors Lp, Royce & Associates LLC, Siena Capital Partners I, L.P., BlackRock Inc., Siena Capital Management, LLC, Renaissance Technologies LLC, Cutler Capital Management, LLC, Vanguard Group Inc, BlackRock Institutional Trust Company, N.A., and Bridgeway Capital Management Inc.
Timberland Bancorp, Inc. (NASDAQ:TSBK) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-11 13F-HR CITIGROUP INC 3,784 2,509 -33.69 100 76 -24.00
2018-05-15 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 105,418 105,318 -0.09 2,799 3,202 14.40
2018-05-15 13F-HR Invesco Ltd. 66,245 0 -100.00 1,758 0 -100.00
2018-05-15 13F-HR DEUTSCHE BANK AG\ 51,177 30,020 -41.34 1,356 911 -32.82
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 300 9
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 1,600 1,600 0.00 42 48 14.29
2018-05-15 13F-HR PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 15,674 18,237 16.35 416 554 33.17
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 15,309 15,676 2.40 406 477 17.49
2017-02-10 13F-HR BlackRock Fund Advisors 1,273 1,813 42.42 20 37 85.00
2018-05-09 13F-HR FEDERATED INVESTORS INC /PA/ 1,378 1,021 -25.91 37 31 -16.22
2018-05-15 13F-HR Context BH Capital Management, LP 84,407 80,116 -5.08 2,241 2,436 8.70
2017-10-26 13F-HR Acrospire Investment Management LLC 2,039 0 -100.00 52 0 -100.00
2018-05-15 13F-HR VANGUARD GROUP INC 271,570 258,003 -5.00 7,210 7,843 8.78
2018-04-20 13F-HR STRS OHIO 12,300 16,700 35.77 326 507 55.52
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 49,909 50,501 1.19 1,325 1,535 15.85
2018-05-15 13F-HR BARCLAYS PLC 2,471 1,660 -32.82 65 50 -23.08
2018-04-18 13F-HR Creative Planning 23,800 25,814 8.46 632 785 24.21
2018-05-02 13F-HR WESTPORT ASSET MANAGEMENT INC 93,093 93,093 0.00 2,918 2,830 -3.02
2018-05-14 13F-HR Pinnacle Holdings, LLC 1,000 1,000 0.00 26,550 30,400 14.50
2018-05-14 13F-HR Renaissance Technologies LLC 338,200 347,500 2.75 8,979 10,564 17.65
2018-05-14 13F-HR MORGAN STANLEY 20,484 18,276 -10.78 543 556 2.39
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 601,950 606,575 0.77 15,982 18,440 15.38
2018-05-01 13F-HR Siena Capital Management, LLC 375,899 348,586 -7.27 9,980 10,597 6.18
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 155,877 124,850 -19.90 2,455 2,579 5.05
2018-04-23 13F-HR Kiley Juergens Wealth Management, Llc 2,150 0 -100.00 57 0 -100.00
2018-05-08 13F-HR O'SHAUGHNESSY ASSET MANAGEMENT, LLC 6,914 7,266 5.09 184 221 20.11
2018-04-12 13F-HR JAMES INVESTMENT RESEARCH INC 3,535 3,535 0.00 94 108 14.89
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 250 250 0.00 7 8 14.29
2017-02-03 SC 13G Siena Capital Partners I, L.P. 375,899
2018-04-25 13F-HR Bowling Portfolio Management LLC 22,284 25,976 16.57 592 790 33.45
2018-05-21 13F-HR Mcilrath & Eck, Llc 650 650 0.00 17 20 17.65
2018-04-26 13F-HR DELTA ASSET MANAGEMENT LLC/TN 8,800 8,800 0.00 234 268 14.53
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 546 546 0.00 14 17 21.43
2018-05-10 13F-HR BESSEMER GROUP INC 11,800 11,800 0.00 313 359 14.70
2018-05-11 13F-HR Delpha Capital Management, Llc 154 0 -100.00 4 0 -100.00
2018-05-10 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 38 1
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 4,192 3,978 -5.10 111 121 9.01
2018-05-15 13F-HR UBS Group AG 698 0 -100.00 19 0 -100.00
2018-05-15 13F-HR STATE STREET CORP 83,633 104,930 25.46 2,220 3,190 43.69
2018-05-03 13F-HR MEEDER ASSET MANAGEMENT INC 332 470 41.57 9 14 55.56
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 70,676 72,261 2.24 1,877 2,197 17.05
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 5,429 5,859 7.92 144 178 23.61
2018-05-14 13F-HR Axa 22,755 16,400 -27.93 604 499 -17.38
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 6,600 6,600 0.00 175 201 14.86
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 40,000 40,000 0.00 1,062 1,216 14.50
2018-05-09 13F-HR BlackRock Inc. 371,886 370,386 -0.40 9,873 11,259 14.04
2018-05-14 13F-HR TEACHERS ADVISORS INC 11,230 11,230 0.00 298 341 14.43
2018-05-15 13F-HR Advisor Group, Inc. 6,719 4,179 -37.80 178 127 -28.65
2018-04-23 13F-HR FIRST TRUST ADVISORS LP 14,341 14,510 1.18 381 441 15.75
2018-05-14 13F-HR FMR LLC / Fidelity 80,827 2,457
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 924 1 -99.89 25 0 -100.00
2018-05-14 13F-HR Royce & Associates LLC 499,428 594,189 18.97 13,260 18,063 36.22
2018-05-09 13F-HR NORTHERN TRUST CORP 76,826 75,916 -1.18 2,040 2,308 13.14
2018-05-11 13F-HR Russell Investments Group, Ltd. 6,990 4,824 -30.99 189 147 -22.22
2018-05-15 13F-HR Ativo Capital Management LLC 37,011 37,011 0.00 983 1,125 14.45
2018-05-10 13F-HR JP Morgan Chase & Co 9,368 8,461 -9.68 249 257 3.21
2018-05-11 13F-HR MARTINGALE ASSET MANAGEMENT L P 29,603 29,603 0.00 786 900 14.50
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 1,842 1,365 -25.90 48,905 41,496 -15.15
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 82,620 70,700 -14.43 2,193 2,151 -1.92
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 9,900 9,478 -4.26 263 288 9.51
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 614 0 -100.00 17 0 -100.00
2018-05-04 13F-HR LSV ASSET MANAGEMENT 58,662 76,954 31.18 1,557 2,339 50.22
2017-02-10 13F-HR BlackRock Investment Management, LLC 1,038 1,038 0.00 16 21 31.25
2018-05-15 13F-HR Bank of New York Mellon Corp 37,770 39,660 5.00 1,002 1,205 20.26
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 1,050 1,050 0.00 28 32 14.29
2018-05-08 13F-HR Cutler Capital Management, LLC 286,351 273,771 -4.39 7,603 8,322 9.46
2018-04-20 13F-HR FIRST QUADRANT L P/CA 10,155 1,924 -81.05 270 58 -78.52
2018-05-15 13F-HR PANAGORA ASSET MANAGEMENT INC 50,731 60,714 19.68 1,347 1,846 37.05
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 2,980 6,422 115.50 79 195 146.84
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 10,427 317
2018-05-14 13F-HR ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 35,427 12,915 -63.54 941 393 -58.24
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 13,805 20,876 51.22 367 635 73.02
2018-05-17 13F-HR Legal & General Group Plc 1,227 1,227 0.00 33 37 12.12

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...

CUSIP: 887098101